RamÃrez-Hernández, D.; Juárez-Osornio, C.; Izquierdo-Sánchez, V.; Figueroa-RodrÃguez, P.A.; Organista-Nava, J.; Gómez-Gómez, Y.; Medina, L.A.
Lipomics: A Potential Carrier for the Intravenous Delivery of Lipophilic and Hydrophilic Drugs. Pharmaceutics 2022, 14, 1651.
https://doi.org/10.3390/pharmaceutics14081651
AMA Style
RamÃrez-Hernández D, Juárez-Osornio C, Izquierdo-Sánchez V, Figueroa-RodrÃguez PA, Organista-Nava J, Gómez-Gómez Y, Medina LA.
Lipomics: A Potential Carrier for the Intravenous Delivery of Lipophilic and Hydrophilic Drugs. Pharmaceutics. 2022; 14(8):1651.
https://doi.org/10.3390/pharmaceutics14081651
Chicago/Turabian Style
RamÃrez-Hernández, David, Carlos Juárez-Osornio, Vanessa Izquierdo-Sánchez, Pavel A. Figueroa-RodrÃguez, Jorge Organista-Nava, YazmÃn Gómez-Gómez, and Luis Alberto Medina.
2022. "Lipomics: A Potential Carrier for the Intravenous Delivery of Lipophilic and Hydrophilic Drugs" Pharmaceutics 14, no. 8: 1651.
https://doi.org/10.3390/pharmaceutics14081651
APA Style
RamÃrez-Hernández, D., Juárez-Osornio, C., Izquierdo-Sánchez, V., Figueroa-RodrÃguez, P. A., Organista-Nava, J., Gómez-Gómez, Y., & Medina, L. A.
(2022). Lipomics: A Potential Carrier for the Intravenous Delivery of Lipophilic and Hydrophilic Drugs. Pharmaceutics, 14(8), 1651.
https://doi.org/10.3390/pharmaceutics14081651
